Skip to main content

Day: February 6, 2020

Financial Results for Fiscal 2020 Third Quarter Ended December 31, 2019

Revenues at $3.891 billion, up 8.8%Adjusted EBITDA at $417.0 million, up 29.8%Net earnings at $197.8 million, down 42.2%Adjusted net earnings at $204.2 million, up 17.1%MONTRÉAL, Feb. 06, 2020 (GLOBE NEWSWIRE) — Saputo Inc. (TSX: SAP) (Saputo or the Company) reported today its financial results for the third quarter of fiscal 2020, which ended on December 31, 2019. All amounts in this news release are in Canadian dollars (CDN), unless otherwise indicated, and are presented according to International Financial Reporting Standards (IFRS).Revenues amounted to $3.891 billion, an increase of $313.6 million or 8.8%.Adjusted EBITDA* amounted to $417.0 million, an increase of $95.8 million or 29.8%.Net earnings totalled $197.8 million and EPS** (basic and diluted) were $0.49 and $0.48, as compared to $342.0 million...

Continue reading

Marel: Correction to note 29 to the 2019 Consolidated Financial Statements

Marel hf. published its 2019 Consolidated Financial Statements after market closing on 5 February 2020, at 19:51 CET.Information on 2019 key management remuneration in note 29 to the Financial Statements was misstated. Attached is a corrected version of the 2019 Consolidated Financial Statements.Investor RelationsFor further information, please contact Marel Investor Relations via email IR@marel.com or tel. (+354) 563 8001.AttachmentMarel 2019 Consolidated Financial Statements_Correction

Continue reading

Marel: Leiðrétting á skýringu 29 í ársreikningi 2019

Marel hf. birti ársuppgjör 2019 eftir lokun markaðar þann 5. febrúar 2020. Frétt birt 18:51 (19:51 CET).Í skýringu 29 við ársreikning 2019 var skekkja í upplýsingum um launakjör lykilstjórnenda fyrir árið 2019 (e. key management remuneration).Meðfylgjandi er leiðréttur ársreikningur fyrir 2019.FjárfestatengslNánari upplýsingar veita fjárfestatenglar Marel í gegnum netfangið IR@marel.com og í síma 563 8001.ViðhengiMarel 2019 Consolidated Financial Statements_Correction

Continue reading

Grieg Seafood ASA: Presentation of fourth quarter 2019 results

Grieg Seafood ASA will release its fourth quarter 2019 results on Thursday, February 13, 2020 at 06:00 CEST.CEO Andreas Kvame and CFO Atle Harald Sandtorv will present the results the same day at 08:00 CEST at Hotel Continental, Stortingsgata 24/26, Oslo.A live webcast from the presentation can be accessed at www.griegseafood.com, or with the following link: https://channel.royalcast.com/webcast/hegnarmedia/20200213_6/ The presentation and subsequent Q&A will be held in Norwegian. An English transcript of the presentation will be made available at www.griegseafood.com after the presentation.RSVP:E-mail: may.hansen@griegseafood.comPhone:  +47 93 45 93 94About Grieg SeafoodGrieg Seafood ASA is one of the world’s leading salmon farmers, specializing inAtlantic salmon. The Group has an annual production target of 100 000...

Continue reading

Funds Managed by Affiliates of Apollo Global Management to Acquire Covis Pharma From Cerberus

AMSTERDAM, Netherlands and NEW YORK, Feb. 06, 2020 (GLOBE NEWSWIRE) — Funds managed by affiliates of Apollo Global Management, Inc. (together with its consolidated subsidiaries, “Apollo”) (NYSE: APO), a leading global alternative investment manager, today announced that they have agreed to acquire Covis Pharma BV (“Covis Pharma” or “Covis”), a global specialty pharmaceutical company, from an affiliate of Cerberus Capital Management, L.P. (“Cerberus”), a global leader in alternative investing.Terms of the transaction were not disclosed. Subject to antitrust approval, the transaction is expected to close by the end of the 1st quarter of 2020.Michael Porter, CEO of Covis Pharma, commented, “We are pleased to announce this strategic investment from Apollo. This transaction facilitates...

Continue reading

Sensus Healthcare to Host Fourth Quarter 2019 Financial Results and Business Update Conference Call on February 13, 2020

BOCA RATON, Fla. , Feb. 06, 2020 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that management will hold a conference call on Thursday, February 13, 2020 at 4:30 p.m. Eastern time to discuss the financial results for the fourth quarter and year ended December 31, 2019. In addition, management will provide a business update and a discussion on recent and upcoming milestones.To access the conference call, the dial-in numbers are 888-567-1603 (U.S. and Canada Toll Free), 862-298-0702 (International). Please direct the operator to be connected to the Sensus Healthcare conference call. The call will be webcast live and can be accessed at the following link, which also may be found...

Continue reading

Advance Notice of Fourth Quarter Financial Results for Shell Midstream Partners, L.P.

Houston, Feb. 06, 2020 (GLOBE NEWSWIRE) — Shell Midstream Partners, L.P.’s Fourth Quarter Earnings Conference Call will be held Thursday, February 20th at 9:00am CST. Shell Midstream Partners’ participants will be Kevin Nichols, President and Chief Executive Officer, Shawn Carsten, Chief Financial Officer and Steve Ledbetter, VP Commercial.                                                                                                                                           ...

Continue reading

Nicholas Financial Reports 3rd Quarter Fiscal Year 2020 Results

Originations year-over-year on new Contracts purchased for the three months ended December 31, 2019 increased by 15.2% compared to prior year third quarter, which included a bulk portfolio purchase of $1.1 millionOriginations year-over-year on Direct Loans for the three months ended December 31, 2019 increased by 49.7% compared to prior year third quarterAccounts 60+ days delinquent decreased to 4.0%, excluding Chapter 13 bankruptcy accounts, compared to 5.7% as of the prior year third quarterGross Portfolio Yield for the three months ended December 31, 2019 increased to 27.3% compared to 25.7% during the prior year third quarterInterest and fee income on finance receivables for the three months ended December 31, 2019 decreased 10.6% due to a 15.9% decrease in average finance receivables, compared to prior year third quarterAverage APR...

Continue reading

Navios Maritime Acquisition Corporation Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2019

Revenue 45.5% increase in Q4 2019 revenue to $85.4 million 49.0% increase in 2019 revenue to $280.1 million Net Cash from Operating Activities$8.2 million in Q4 2019 $29.2 million in 2019 EBITDA148.6% increase in Q4 2019 EBITDA to $45.9 million 170.0% increase in 2019 EBITDA to $128.4 million Liquidation of Navios Europe Inc.Acquisition of five product tankers$33.2 million receivables transformed into steel valueReturning capital to stockholders:Quarterly dividend: $0.30 per shareMONACO, Feb. 06, 2020 (GLOBE NEWSWIRE) — Navios Maritime Acquisition Corporation (“Navios Acquisition”) (NYSE: NNA), an owner and operator of tanker vessels, reported its financial results today for the fourth quarter and the year ended December 31, 2019.Angeliki Frangou, Chairman and Chief Executive Officer...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.